Skip to content

Clinical trials

Completed Observational Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Observational Status: Completed Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20033
20043
20056
20061
20072
20085
20096
201012
20117
20125
20138
20146
20153
20167
20179
20186
20196
20202
20212
20225
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed116

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Bristol-Myers Squibb4
The University of Hong Kong4
Chinese University of Hong Kong3
Gilead Sciences3
National Institutes of Health Clinical Center (CC)3
ANRS, Emerging Infectious Diseases2
Corporacion Parc Tauli2
First Affiliated Hospital Xi'an Jiaotong University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B116
Hepatitis C22
HIV Infections15
Carcinoma, Hepatocellular11
Acquired Immunodeficiency Syndrome8
Hepatitis B, Chronic7
Liver Cirrhosis7
Fibrosis5
Hepatitis5
Hepatitis A4

Trials

Showing 1 to 25 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.